Role of the endocannabinoid system in management of patients with type 2 diabetes mellitus and cardiovascular risk factors.

“To review the role of the endogenous cannabinoid system (ECS) in the peripheral and central regulation of food intake, appetite, and energy storage and discuss the potential for the ECS to be an important target for lowering cardiovascular risk…

The ECS has been shown to have a key role in the regulation of energy balance, and modulation of this system may affect multiple cardiometabolic risk factors.

Clinical studies involving pharmacologic blockade of CB1 receptors in overweight patients with and without type 2 diabetes have demonstrated effective weight loss and improvements in several risk factors for cardiovascular disease.”

http://www.ncbi.nlm.nih.gov/pubmed/18194939

http://www.thctotalhealthcare.com/category/diabetes/

Leave a Reply

Your email address will not be published. Required fields are marked *